Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:1207-1210

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernardes-Silva, H.
Right arrow Articles by Maranhão, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernardes-Silva, H.
Right arrow Articles by Maranhão, R. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLYCERYL TRIOLEATE

(Hypertension. 1995;26:1207-1210.)
© 1995 American Heart Association, Inc.


Articles

Malignant Hypertension Is Accompanied by Marked Alterations in Chylomicron Metabolism

Helio Bernardes-Silva; Odaly Toffoletto; Luiz A. Bortolotto; Maria C.M. Latrilha; Eduardo M. Krieger; Fulvio Pileggi; Raul C. Maranhão

From the Heart Institute of the Medical School Hospital and Faculty of Pharmaceutical Sciences, University of São Paulo (Brazil).

Correspondence to Raul C. Maranhão, MD, PhD, Instituto do Coração do Hospital das Clínicas da FMUSP, Av Dr Enéas C. Aguiar 44, 1o Andar, São Paulo, SP, 05403-000, Brazil.

Abstract Malignant hypertension (MH) is a severe complication of untreated arterial hypertension that damages the vascular system. It is often accompanied by disturbances in lipid metabolism that could contribute to its pathophysiology. We examined chylomicron metabolism in MH patients using a triglyceride-rich emulsion known to mimic natural chylomicrons when injected into the bloodstream. The emulsion was labeled with [3H]triolein and [14C]cholesteryl oleate and injected intravenously into 15 normolipidemic MH patients aged 29 to 56 years (8 men) for comparison with 17 healthy control subjects. Consecutive plasma samples were taken at regular intervals during 1 hour for determination of the disappearance curves of the labels. The fractional clearance rate of the [3H]triolein emulsion in MH patients was twice as small as that of control subjects (0.061±0.012 and 0.141±0.074 min-1, respectively). On the other hand, [14C]cholesteryl oleate fractional clearance rate was not statistically different in MH patients and control subjects (0.032±0.004 and 0.056±0.014 min-1, respectively). These results indicate that in MH, lipolysis (measured by the fractional clearance rate of [3H]triolein) is pronouncedly diminished, whereas the removal of the remnant particles (measured by the fractional clearance rate of [14C]cholesteryl oleate) is not importantly affected. In conclusion, there is an alteration in the circulatory transport of dietary lipids that may be an important component in the vascular disease associated with MH.


Key Words: hypertension, malignant • chylomicron • emulsions




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
T. G. Redgrave, G. F. Watts, I. J. Martins, P. H. R. Barrett, J. C. L. Mamo, S. B. Dimmitt, and A. D. Marais
Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test
J. Lipid Res., May 1, 2001; 42(5): 710 - 715.
[Abstract] [Full Text]